Robert P. Roche Jr., Executive VP, WW Pharmaceutical Operations at CEPHALON INC (CEPH), sold 26,239 shares at $75.78 ($2.0M) on 2007-12-12, disclosed to the SEC on 2007-12-14.
Open-market sale of $2.0M CEPH by Executive VP, WW Pharmaceutical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.75 | 2,000 | $152K | 7.6% |
| 2 | $75.76 | 1,077 | $82K | 4.1% |
| 3 | $75.78 | 1,069 | $81K | 4.1% |
| 4 | $75.79 | 5,277 | $400K | 20.1% |
| 5 | $75.80 | 6,507 | $493K | 24.8% |
| 6 | $75.81 | 4,099 |
| $311K |
| 15.6% |
| 7 | $75.82 | 1,292 | $98K | 4.9% |
| 8 | $75.83 | 647 | $49K | 2.5% |
| 9 | $75.84 | 200 | $15K | 0.8% |
| 10 | $75.86 | 1,163 | $88K | 4.4% |
| 11 | $75.87 | 608 | $46K | 2.3% |
| 12 | $75.88 | 2,300 | $175K | 8.8% |
| Total | $75.81 avg | 26,239 | $2.0M | 100% |
| Filing → |
| ATRS | BUY | 2015-08-17 | $10K | — | Filing → |
| ATRS | BUY | 2014-08-14 | $10K | — | Filing → |
| PATH | BUY | 2011-09-19 | $27K | — | Filing → |